Company Filing History:
4 out of 444 
4 out of 5,450 
Years Active: 2010-2015
Title: The Innovations of Jay D. Horton
Introduction
Jay D. Horton is a notable inventor based in Plano, Texas, recognized for his contributions to the field of molecular biology and therapeutic innovations. With a total of four patents to his name, Horton has made significant strides in the modulation of gene expression, particularly concerning the SCAP gene.
Latest Patents
One of Horton’s latest patents focuses on RNA interference (RNAi) modulation of the SCAP gene. This invention involves a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the Human SCAP gene. The dsRNA comprises an antisense strand with a nucleotide sequence that is generally 19-25 nucleotides in length and is substantially complementary to a part of the SCAP gene. The patent also details a pharmaceutical composition that includes the dsRNA along with a pharmaceutically acceptable carrier. Furthermore, it outlines methods for treating diseases caused by the expression of the Human SCAP gene and techniques for inhibiting this gene's expression in cells.
Career Highlights
Throughout his career, Jay D. Horton has worked with prominent organizations, including Alnylam Pharmaceuticals, Inc. and the University of Texas System. His work has significantly impacted the development of therapeutic strategies targeting gene expression.
Collaborations
Horton has collaborated with esteemed colleagues such as Juergen Soutschek and Pamela Tan, contributing to advancements in his field.
Conclusion
Jay D. Horton’s innovative work in RNAi modulation and gene therapy exemplifies the potential of scientific research to address complex medical challenges. His patents and collaborations reflect a commitment to advancing therapeutic applications in molecular biology.